Question 1

What is the catalog number for Anti-IL13 (Lebrikizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC?

Accepted Answer

The catalog number for Anti-IL13 (Lebrikizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC is ADC-W-1309.

Question 2

What sizes are available for Anti-IL13 (Lebrikizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC?

Accepted Answer

Anti-IL13 (Lebrikizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC is available in the following size(s): 1 mg.

Question 3

Is Anti-IL13 (Lebrikizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC in stock?

Accepted Answer

Anti-IL13 (Lebrikizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is Anti-IL13 (Lebrikizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC used for?

Accepted Answer

This ADC product is comprised of an anti-IL13 monoclonal antibody conjugated via a MC-Vc-PAB-DMEA-(PEG2) linker to duocarmycin SA. The duocarmycin SA is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell,

Question 5

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

Question 6

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Question 7

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Anti-IL13 (Lebrikizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC

Product Specifications

CAS Number

Format

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

CD79b (B-Cell Marker) (IGB/3170R), CF740 conjugate, 0.1mg/mL

Anti-TIE2/TEK Antibody Picoband®, HRP Conjugate

CD71 (TFRC/1149), CF647 conjugate, 0.1mg/mL

Cyclin D1 (DCS-6), CF640R conjugate, 0.1mg/mL

Calpain 1 (CAPN1/1530), CF647 conjugate, 0.1mg/mL

EGFR (Epidermal Growth Factor Receptor) (rGFR/1667), Biotin conjugate, 0.1mg/mL